Michel Papo

840 total citations
10 papers, 553 citations indexed

About

Michel Papo is a scholar working on Surgery, Epidemiology and Gastroenterology. According to data from OpenAlex, Michel Papo has authored 10 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Epidemiology and 4 papers in Gastroenterology. Recurrent topics in Michel Papo's work include Inflammatory Bowel Disease (4 papers), Microscopic Colitis (2 papers) and Eosinophilic Esophagitis (2 papers). Michel Papo is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Microscopic Colitis (2 papers) and Eosinophilic Esophagitis (2 papers). Michel Papo collaborates with scholars based in Spain, United States and Palestinian Territory. Michel Papo's co-authors include Miquel A. Gassull, Albert Parés, Joan Carles Quer, Eduard Cabré, Joan Caballería, Ramón Planas, Félix Junquera, Juan‐Ramón Malagelada, José Ramón Armengol and Josep M. Piqué and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Science.

In The Last Decade

Michel Papo

10 papers receiving 527 citations

Peers

Michel Papo
Comparison fields: 5 of 53
  • Epidemiology 290
  • Surgery 175
  • Pathology and Forensic Medicine 168
  • Gastroenterology 164
  • Genetics 132
Replace Yoshiko Kadokawa with:
Yoshiko Kadokawa Japan
V. Canva-Delcambre France
J. A. Solís Herruzo Spain
Masaharu Ando Japan
John Hsiang Singapore
Thomas F. Mangan United States
Conor Lahiff Ireland
Yong Eun Park South Korea
Mansour Jabbari Canada
Xiaorong Gong China
Yoshiko Kadokawa Japan View profile →
Citations per field, relative to Michel Papo
Michel Papo · 1×
Citations per year, relative to Michel Papo
Michel Papo · 1×

Countries citing papers authored by Michel Papo

Since Specialization
Citations

This map shows the geographic impact of Michel Papo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Papo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Papo more than expected).

Fields of papers citing papers by Michel Papo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Papo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Papo. The network helps show where Michel Papo may publish in the future.

Co-authorship network of co-authors of Michel Papo

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Papo. A scholar is included among the top collaborators of Michel Papo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Papo. Michel Papo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Work Indexed citations
1 7
2 77
3 2
4 44
5 163
6 6
7 230
8 11
9
[antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
4
10 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026